PMID: 6539552Jun 1, 1984Paper

Comparison of growth and somatomedin C responses following growth hormone treatment in children with small-for-date short stature, significant idiopathic short stature and hypopituitarism

Acta Endocrinologica
J A GruntW H Daughaday

Abstract

Somatomedin-C (Sm-C) and growth hormone (GH) levels were determined before, during and after human growth hormone (hGH) treatment in 18 children with small-for-date short stature ( SDSS ), 7 children with significant idiopathic short stature ( SISS ) and 14 children with hypopituitarism. Data on the acute effects of hGH on Sm-C were compared to growth responses after 6 to 9 months therapy. Eleven of the 25 non-hypopituitary patients with normal basal and stimulated serum GH levels and normal basal Sm-C levels increased their rates of growth more than 3.0 cm/year. This compared with 11 of the 14 children with hypopituitarism who increased their rates of growth by at least 3.0 cm/year when treated with GH. Neither the basal somatomedin levels nor the GH-stimulated somatomedin levels correlated well with subsequent growth in the non-hypopituitary patients. These studies indicate that GH therapy may be effective in treating short stature in children without demonstrable GH deficiency.

Citations

Mar 1, 1986·Indian Journal of Pediatrics·M J Bourgeois
Oct 7, 2008·Advances in Therapy·Heike JungStenvert L S Drop
Jun 1, 1987·The Journal of Pediatrics·B B Bercu
Dec 1, 1989·Archives of Disease in Childhood·J K Wales, R D Milner
Feb 1, 1993·Archives of Disease in Childhood·J W GregoryM J Rennie
Nov 8, 1986·British Medical Journal·M A Preece
Oct 1, 1992·Current Problems in Pediatrics·J A Grunt, I D Schwartz
Sep 6, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Caterina Geremia, Stefano Cianfarani
Aug 1, 1986·Clinics in Endocrinology and Metabolism·B B Bercu, F B Diamond
Jan 1, 1989·Acta Paediatrica Scandinavica. Supplement·L E Underwood, P A Rieser
Jan 1, 1989·Acta Paediatrica Scandinavica. Supplement·S A Ivarsson
Jan 1, 1989·Acta Paediatrica Scandinavica. Supplement·L Hagenäs
Jan 1, 1989·Acta Paediatrica Scandinavica. Supplement·P RochiccioliC Pienkowski
Jan 1, 1986·Acta Paediatrica Scandinavica. Supplement·K Albertsson-Wikland
May 1, 1986·Acta paediatrica Scandinavica·J Knudtzon
Jan 1, 1990·Acta Paediatrica Scandinavica. Supplement·M Vanderschueren-Lodeweyckx
Feb 27, 2007·Endocrine Reviews·Paul SaengerEdward O Reiter
Jan 1, 1989·Acta Paediatrica Scandinavica. Supplement·Z Zadik, A Kowarski
Sep 5, 1987·British Medical Journal·P C Hindmarsh, C G Brook
Jan 1, 1988·Acta Paediatrica Scandinavica. Supplement·K Albertsson-Wikland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
G Van VlietM M Grumbach
Acta Paediatrica Scandinavica. Supplement
K Albertsson-Wikland
Acta Paediatrica Scandinavica. Supplement
P ChatelainJ Saez
The Journal of Pediatrics
T FrazerV V Weldon
© 2021 Meta ULC. All rights reserved